Best Clinics and Costs for Otorhinolaryngology/Ear, Nose and Throat(ENT) in United Arab Emirates 2024

Dr. Shahriyar is a European Board-Certified Specialist Otorhinolaryngologist and Head and Neck Surgeon with over 14 years of experience in ENT and Head and Neck Surgery. He also possesses a Master’s Degree in Otorhinolaryngology and Head and Neck Surgery from India and MRCS in ENT from Royal College of Surgeons Edinburgh, UK. Dr. Shahriyar, is a seasoned ENT surgeon with vast ENT Experience. Moreover, his international engagements include working in King Fahad Medical City, Riyadh, Saudi Arabia, one of the largest tertiary care ENT and Head and Neck Oncology Institute adding precious experience to his expertise in dealing with comprehensive ENT & Head and Neck Disorders. In India, He has worked with Apollo Hospitals Group one of the biggest and the oldest Healthcare provider in India. Dr Shahriyar has a zeal to stay updated in the fast changing medical field by meticulously continuing medical education, participating frequently in meetings and national and International conferences. EXPERTISE: Paediatric ENT -Tonsillectomy and Adenoidectomy using advanced cobalators and harmonic scalpel. Sinusitis and Nasal Allergy – Medical and Surgical Management including FESS Ear Infections and Hearing Disorders Snoring and Sleep Apnoea Management in Children and Adults Neuro-Otology- Dizziness, Headache and Vertigo Management Voice and Speech Disorders Head & Neck Disorders - Surgical Management All ENT Endoscopies - Diagnostic and Therapeutic" CERTIFICATES: Board Certification & Fellow European Board of Otolaryngology and Head and Neck Surgery Member Royal College of Surgeons Lifetime Member Association of Otolaryngologist of India Member ENT UK Member The British Society of Otology

Dr. Murat Binar is a Specialist in Otolaryngology with 8 years of experience in his field. He graduated from Medical Faculty of Gülhane Military Medical Academy (GATA) in Turkey, in 2008 and further specialised at GATA Department of Otolaryngology, between 2011-2015. After he had completed his compulsory service in government hospitals, he had worked in reputed private hospitals in İstanbul before coming to Dubai. Besides general ENT disorders of adults and children, Dr. Binar is interested in aesthetic nasal surgeries (rhinoplasty), functional nasal surgeries and the management of obstructive sleep apnoea. Considering total of 12-year experience in otorhinolaryngology, he has followed the surgical evolution of rhinoplasty through years, via watching the hands of master's and taking many courses in Turkey, which is one of the leading countries of rhinoplasty world. Apart from surgical and clinical practice, he has been the part of a considerable number of research/clinical studies. He has more than 40 articles published in respected journals, more than 50 presentations in national/international congresses, and more than 150 citations from reputed otorhinolaryngology journals. In addition, he has been constantly invited for reviewer role from prestigious otolaryngology journals. He was also a lecturer to medical students at GATA Department of Otolaryngology between 2016-2018.

Biography Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following: Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy Breast cancer Solid tumor diagnosis Digestive cancer Gynecological cancer Lung cancer Genitourinary cancer Sarcoma Awards & Achievements Award from Himaya Foundations and University of Sharjah Research & Publications Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3. The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6. The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6. The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87. Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272. First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21